Novo Nordisk AS (NVO)
105.88
+3.25
(+3.17%)
USD |
NYSE |
Nov 22, 13:35
Novo Nordisk Shareholders Equity (Quarterly): 18.05B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 18.05B |
| June 30, 2024 | 16.15B |
| March 31, 2024 | 14.31B |
| December 31, 2023 | 15.82B |
| September 30, 2023 | 13.17B |
| June 30, 2023 | 13.20B |
| March 31, 2023 | 11.69B |
| December 31, 2022 | 12.02B |
| September 30, 2022 | 10.13B |
| June 30, 2022 | 10.45B |
| March 31, 2022 | 9.987B |
| December 31, 2021 | 10.77B |
| September 30, 2021 | 10.31B |
| June 30, 2021 | 10.49B |
| March 31, 2021 | 9.220B |
| December 31, 2020 | 10.47B |
| September 30, 2020 | 9.393B |
| June 30, 2020 | 9.059B |
| March 31, 2020 | 8.034B |
| December 31, 2019 | 8.634B |
| September 30, 2019 | 7.760B |
| June 30, 2019 | 8.087B |
| March 31, 2019 | 7.111B |
| December 31, 2018 | 7.941B |
| September 30, 2018 | 7.392B |
| Date | Value |
|---|---|
| June 30, 2018 | 7.613B |
| March 31, 2018 | 7.313B |
| December 31, 2017 | 8.028B |
| September 30, 2017 | 7.431B |
| June 30, 2017 | 7.451B |
| March 31, 2017 | 5.789B |
| December 31, 2016 | 6.438B |
| September 30, 2016 | 6.220B |
| June 30, 2016 | 6.367B |
| March 31, 2016 | 5.669B |
| December 31, 2015 | 6.880B |
| September 30, 2015 | 6.503B |
| June 30, 2015 | 5.880B |
| March 31, 2015 | 4.655B |
| December 31, 2014 | 6.579B |
| September 30, 2014 | 6.472B |
| June 30, 2014 | 6.707B |
| March 31, 2014 | 6.184B |
| December 31, 2013 | 7.879B |
| September 30, 2013 | 7.079B |
| June 30, 2013 | 6.178B |
| March 31, 2013 | 5.809B |
| December 31, 2012 | 7.202B |
| September 30, 2012 | 6.175B |
| June 30, 2012 | 5.244B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
8.034B
Minimum
Mar 2020
18.05B
Maximum
Sep 2024
11.57B
Average
10.48B
Median
Shareholders Equity (Quarterly) Benchmarks
| Ascendis Pharma AS | -108.70M |
| Amgen Inc | 7.527B |
| AstraZeneca PLC | 40.72B |
| Grifols SA | 5.975B |
| Viking Therapeutics Inc | 911.45M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.53B |
| Total Liabilities (Quarterly) | 41.48B |
| Debt to Equity Ratio | 0.4727 |
| Current Ratio | 0.9367 |
| Net Debt Paydown Yield | -0.18% |